Source: International Congress 2014 – The rise in non-tuberculous mycobacteria (NTM) pulmonary diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Andrejak (Amiens, France). Risk factors of pulmonary NTM disease in COPD: how bad are glucocorticoids?. International Congress 2014 – The rise in non-tuberculous mycobacteria (NTM) pulmonary diseases

Member's Comments

No comment yet.

Related content which might interest you: Comorbidities in chronic obstructive pulmonary disease: Prognostic factors? Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Pulmonary nocardiosis in immunocompetent patients: can COPD be the only risk factor? Source: Eur Respir Rev 2011; 20: 210-212 Year: 2011 Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Hypoperfusion is the main risk factor for the development of non-tuberculous mycobacterial lung disease in CTEPH Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Risk factors for chronic obstructive pulmonary disease in women Source: Eur Respir J 2002; 20: Suppl. 38, 326s Year: 2002 Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease Source: Eur Respir J 2016; 48: 928-931 Year: 2016 Cardiovascular risk factors in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Risk factors for tuberculosis in patients with chronic alcoholism Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021 The CANT score: Predicting mortality in exacerbations of chronic obstructive pulmonary disease Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Risk factors associated with death in pulmonary tuberculosis Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009 Risk factors and treatment outcomes in patients with chronic pulmonary aspergillosis Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 COPD mortality - Is it all COPD? Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Risk factors for asthma exacerbations: is severity a predictor? Source: Annual Congress 2003 - Burden of asthma Year: 2003 Risk factors for pulmonary Mycobacterium avium-intracellulare complex disease deterioration in immunocompetent patients Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Risk of pneumonia in chronic obstructive pulmonary disease patients treated with inhaled corticosteroids. Results from the OUTPUL study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Risk factors for chronic pulmonary aspergillosis in a low prevalence country and their effect on survival Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Lung cancer in patient with chronic obstructive pulmonary disease (comorbidity by smokers-a cumulative effect of exogenic and endogenic factors? Part II) Source: Annual Congress 2013 –COPD treatment Year: 2013 Pulmonary hypertension and chronic lung disease: where are we headed? Source: Eur Respir Rev, 28 (153) 190065; 10.1183/16000617.0065-2019 Year: 2019